(-0.08%) 5 464.74 points
(-0.06%) 39 087 points
(0.16%) 17 746 points
(-0.72%) $80.25
(-4.32%) $2.64
(-0.85%) $2 310.90
(0.01%) $28.87
(2.30%) $1 009.10
(0.31%) $0.936
(0.74%) $10.68
(0.48%) $0.792
(-0.14%) $87.37
Live Chart Being Loaded With Signals
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases...
Stats | |
---|---|
Today's Volume | 302 596 |
Average Volume | 898 703 |
Market Cap | 769.36M |
EPS | $-0.540 ( Q1 | 2024-05-09 ) |
Next earnings date | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.91 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0190 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Babler Martin | Buy | 67 700 | Stock Option (Right to Buy) |
2024-04-13 | Babler Martin | Buy | 0 | |
2024-04-11 | Ra Capital Management, L.p. | Buy | 1 408 450 | Common Stock |
2024-02-01 | Ra Capital Management, L.p. | Buy | 45 150 | Stock Option (Right to Buy) |
2023-02-09 | Ra Capital Management, L.p. | Buy | 27 400 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
35.05 |
Last 99 transactions |
Buy: 8 717 496 | Sell: 3 336 793 |
Volume Correlation
89Bio Inc Correlation
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
89Bio Inc Correlation - Currency/Commodity
89Bio Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-273 000 (0.00 %) |
EPS: | $-2.00 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-273 000 (0.00 %) |
EPS: | $-2.00 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-240 000 (0.00 %) |
EPS: | $-2.93 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-4.48 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
89Bio Inc
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators